Imatinib shows improved outcomes for patients with severe COVID-19 in the CounterCOVID clinical trial
Increased flexibility seen in preapproval evidence for new drugs
18 May 2022Choline makes a key nutrient available for baby development
18 May 2022Imatinib shows improved outcomes for patients with severe COVID-19 in the CounterCOVID clinical trial
Patients with severe COVID-19 who were given imatinib had lower mortality rates at 90-day follow-up, according to research published at the ATS 2022 international conference.
